Ligne de temps
Jeanne Chiaravalli
Ingénieur(e) de Recherche
21 avr. 2023
publication
Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages.
Lire plus22 mars 2023
04 juil. 2022
publication
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
Lire plus17 juin 2022
news
New publication – Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2
Lire plus01 mai 2022
publication
A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors.
Lire plus21 sept. 2021
publication
Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential.
Lire plus01 sept. 2021
publication
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.
Lire plus25 mai 2021
publication
Small-molecule inhibition of Lats kinases may promote Yap-dependent proliferation in postmitotic mammalian tissues.
Lire plus05 juin 2015